ShapeTX
Ken Prentice has a diverse background in the field of analytical and process development in the biotech and pharmaceutical industries. With experience in leading teams and conducting research at companies like Shape Therapeutics Inc., Juno Therapeutics, and Amgen, Ken specializes in the analysis and development of proteins, peptides, and small molecules for various therapeutic processes. Prior to their industry experience, Ken worked as a Forensic Scientist at the Washington State Patrol and as a Student Research Assistant at the University of Washington. With a degree in Chemistry and Oceanography from the University of Washington, Ken has a solid foundation in science and research.
ShapeTX
1 followers
Shape Therapeutics is a biotechnology company developing next-generation RNA-targeted therapies to treat the world’s most challenging diseases.